banner2

Getting started
Ethyl Isonicotinate CAS 1570-45-2

Ethyl Isonicotinate CAS 1570-45-2 - China Factory, Suppliers, Manufacturers

Ethyl Isonicotinate CAS 1570-45-2, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

Ethyl Isonicotinate CAS 1570-45-2 Purity 99.0 (GC) Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Ethyl Isonicotinate CAS 1570-45-2 Purity >99.0% (GC)
Read More

Ethyl Isonicotinate CAS 1570-45-2 Purity 99.0 GC Factory — Ethyl Isonicotinate CAS 1570-45-2 Purity >99.0% (GC) Factory

Methyl 2-Methoxyisonicotinate CAS 26156-51-4 Purity 98.0 (HPLC) Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Methyl 2-Methoxyisonicotinate CAS 26156-51-4 Purity >98.0% (HPLC)

Methyl 2-Methoxyisonicotinate CAS 26156-51-4 Purity 98.0 — Methyl 2-Methoxyisonicotinate CAS 26156-51-4 Purity >98.0% (HPLC)

Methyl Isonicotinate CAS 2459-09-8 Purity 99.0 (GC) Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Methyl Isonicotinate CAS 2459-09-8 Purity >99.0% (GC) Factory

Methyl 2-Bromoisonicotinate CAS 26156-48-9 — Methyl 2-Bromoisonicotinate CAS 26156-48-9 Purity ≥98.0% Factory

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

banner1

Top Selling Products

Related Blog
Reviews

Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021 As the world’s second largest medical market, ...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The 3rd CMC-China 2021 Time: September 29-30, 2021 Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China. Synergy of Centralized China’s Drug Volume-ba...
The 87th China International Pharmaceutical Apis/Intermediates/Packaging/Equipment Fair (API China) -Shanghai Ruifu Chemical Co., Ltd. will attend with customers.

Shanghai Ruifu Chemical Co., Ltd. will attend the The 87th China International Pharmaceutical Apis/Intermediates/Packaging/Equipment Fair (API China) with customers. The 87th China International ...

2022.09.08 21:35:25
2022.08.11 10:13:18
2022.07.09 15:21:39
2022.05.06 01:59:53
2021.11.18 03:32:07
2021.11.04 16:13:24

related search